Patent ID: 11938217
Assignee: SLAYBACK PHARMA LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A stable ready-to-use injectable pharmaceutical composition for reversing effects of non-depolarizing neuromuscular blocking agents in a patient in need thereof, comprising:
(i) about 1 mg/mL of neostigmine or a pharmaceutically acceptable salt, solvate or hydrate thereof,
(ii) about 0.2 mg/mL of glycopyrrolate or a pharmaceutically acceptable salt, solvate or hydrate thereof, and
(iii) a pharmaceutically acceptable liquid vehicle,
wherein the pharmaceutical composition has a pH ranging from 3.0 to 4.0, and
wherein said composition is stable when stored at 40° C. and 75% relative humidity for at least 3 months.